Tacrolimus blood levels should be drawn 12 hours after your last dose, immediately before you take the next one. This is called a trough level, and it captures the drug at its lowest concentration in your bloodstream. The timing matters because tacrolimus peaks about 2 to 3 hours after you swallow it, then slowly drops. Drawing blood at the wrong time gives a misleading number that can lead to unnecessary dose changes.
Why the 12-Hour Trough Matters
Tacrolimus has a narrow therapeutic window, meaning the difference between too little (risking rejection) and too much (risking kidney damage) is small. Trough levels are the standard way clinicians track whether you’re in that sweet spot. If you take the twice-daily formulation, the 12-hour mark lines up neatly with your next scheduled dose. In practice, this means you take your evening dose, skip your morning dose, go to the lab first thing, get your blood drawn, and then take your morning dose right after.
If you accidentally take your morning dose before the draw, let your transplant team know. The result will read higher than your true trough, and your team needs that context to interpret the number correctly.
Timing Differs by Formulation
The standard twice-daily version (Prograf) is dosed every 12 hours, so the trough draw naturally falls right before the next pill. Extended-release versions taken once daily, such as Advagraf or Envarsus XR, follow the same principle: blood is drawn 24 hours after the last dose, just before the next one. The goal is identical, capturing the lowest point in the drug’s cycle, but the clock resets on a longer interval.
Extended-release tacrolimus also behaves differently in your body. One formulation has a median effective half-life of about 48 hours, roughly twice as long as the immediate-release version. That means dose changes take longer to fully show up in your blood. Labeling states steady state is reached in about 7 days, but research shows that for a quarter of patients, less than 78% of the final steady-state level is actually achieved by day 7. Your team may wait longer than a week after a dose adjustment before trusting a new trough reading, especially with extended-release formulations.
How Often Levels Are Checked
Monitoring frequency changes dramatically over time. In the first weeks after a transplant, expect blood draws as often as three times per week. Levels are checked daily during the initial hospital stay (typically 6 to 7 days post-transplant), then remain frequent after discharge. As your levels stabilize within the target range and your doses stop changing, the frequency gradually decreases.
During months 2 through 6, most programs still check levels regularly, often at each clinic visit. From 6 to 12 months, the interval stretches further. Years out from transplant, stable patients may only need levels checked every few months. But any time your dose changes, you start a new medication that could interact with tacrolimus, or you develop symptoms of toxicity, your team will likely increase the frequency again.
Waiting for Steady State
A trough level is only meaningful if the drug has had time to stabilize in your system. For the standard twice-daily formulation, steady state is typically reached within about 3 to 5 days of consistent dosing. For extended-release versions, plan on at least 7 days, and possibly longer for some patients. The clinical rule of thumb is that steady state requires at least five half-lives of consistent dosing with no dose changes in the preceding 3 days.
This is why your team won’t keep adjusting your dose every day based on a single blood draw. After each change, they’ll wait for the new steady state before rechecking. Drawing a level too soon after a dose adjustment can make it look like you need a bigger change than you actually do.
Target Ranges for Kidney Transplant
The target trough level isn’t one fixed number. It shifts downward over time as the risk of acute rejection decreases and the priority shifts toward protecting your kidneys from long-term drug toxicity. A large multicenter study found the following ranges associated with the best graft outcomes in kidney transplant recipients:
- 2 to 6 months post-transplant: 7.0 to 10.0 ng/mL
- 6 to 12 months: 6.0 to 8.0 ng/mL
- After 12 months: 5.0 to 8.0 ng/mL
Longer-term data suggest that levels of 5.0 to 6.9 ng/mL between 1 and 6 years post-transplant are associated with the lowest risk of graft complications. Early protocols used to target levels as high as 15 to 20 ng/mL, but the landmark ELITE-Symphony trial established that lower targets of 5 to 10 ng/mL delivered better outcomes with fewer side effects. Targets for liver, heart, and lung transplants follow different protocols, so your specific range depends on your transplant type and your center’s guidelines.
Foods and Supplements That Shift Levels
Tacrolimus is broken down by a specific liver enzyme, and anything that speeds up or slows down that enzyme will change your blood levels, sometimes dramatically. Knowing these interactions matters because an unexpected spike or drop in your trough level might not mean your dose is wrong. It might mean something in your diet changed.
Foods and supplements that can raise tacrolimus levels by slowing its breakdown include grapefruit and grapefruit juice (the most well-studied interaction), pomelo, clementine, pomegranate, ginger, turmeric, and green tea. In one case, eating just one or two pomegranate popsicles daily doubled a patient’s tacrolimus blood concentration. Green tea raised levels in another case report, and they returned to normal after the tea was stopped.
On the other side, St. John’s Wort, a popular herbal supplement for mild depression, is considered outright contraindicated with tacrolimus. It can slash drug levels by more than 50%, putting you at serious risk of rejection. One clinical trial found that 600 mg per day of St. John’s Wort extract for just 14 days reduced tacrolimus exposure by nearly 58%.
If you start or stop any of these foods or supplements, your team will likely want to recheck your levels sooner than scheduled.
Signs Your Level May Be Too High
Tacrolimus toxicity tends to announce itself through a few common symptoms. Tremors, especially a fine shaking in the hands, are one of the earliest and most recognizable signs. Nausea, headaches, and elevated liver enzymes on routine blood work can also point to levels that have crept too high. The most concerning effect is kidney damage, which may not cause symptoms you can feel but shows up as rising creatinine on lab tests.
These symptoms don’t always correlate perfectly with a single blood level. Some people tolerate higher numbers without problems, while others develop side effects even within the target range. That’s part of why regular monitoring continues for the life of the transplant.
Practical Tips for Accurate Results
The blood sample needs to be collected in a specific purple-topped tube (EDTA) and sent as whole blood, not separated into serum. About 90% of tacrolimus binds to red blood cells, so spinning the blood down and testing only the liquid portion would miss most of the drug. Your lab handles this, but if you’re ever having blood drawn at an unfamiliar facility, make sure the order specifies whole blood EDTA.
Consistency is the other key factor. Try to take your doses at the same times each day, and schedule your blood draw at the same point in the dosing cycle. If your appointment is delayed by a few hours, take note of the actual time gap since your last dose and mention it to your team. Even a one- or two-hour difference can shift a trough reading enough to affect clinical decisions.